Home > Financial Ratios > THEMIS MEDICARE

THEMIS MEDICARE
Core EBITDA Growth

    Back to All Ratios
THEMIS MEDICARE is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for THEMIS MEDICARE
Please provide your vote to see the results

THEMIS MEDICARE Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -4.52-28.74-22.7392.3735.77

What is the latest Core EBITDA Growth ratio of THEMIS MEDICARE ?

The latest Core EBITDA Growth ratio of THEMIS MEDICARE is -4.52 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-4.52
Mar2024-28.74
Mar2023-22.73
Mar202292.37
Mar202135.77

How is Core EBITDA Growth of THEMIS MEDICARE Trending?

Years Core EBITDA Growth % Change
Mar2025 -4.52
Negative
Mar2024 -28.74
Negative
Mar2023 -22.73
Negative
Mar2022 92.37
158.23
Mar2021 35.77 -

Other Financial Ratios of THEMIS MEDICARE


Compare Core EBITDA Growth ratio of peers of THEMIS MEDICARE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
THEMIS MEDICARE ₹744.2 Cr 0.4% -20.6% -69.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,329.0 Cr -0.2% -6.3% -8.8% Stock Analytics
DIVIS LABORATORIES ₹164,674.0 Cr 3.3% -3.4% 4% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,891.0 Cr -0.7% 3.8% 26.3% Stock Analytics
CIPLA ₹107,292.0 Cr -3% -11.8% -8.8% Stock Analytics
DR REDDYS LABORATORIES ₹102,184.0 Cr 6% -3.5% -4.3% Stock Analytics


THEMIS MEDICARE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
THEMIS MEDICARE

0.4%

-20.6%

-69.3%

SENSEX

0.2%

-3.6%

8.6%


You may also like the below Video Courses